全文获取类型
收费全文 | 40645篇 |
免费 | 2657篇 |
国内免费 | 1531篇 |
专业分类
耳鼻咽喉 | 666篇 |
儿科学 | 626篇 |
妇产科学 | 536篇 |
基础医学 | 7518篇 |
口腔科学 | 1039篇 |
临床医学 | 3507篇 |
内科学 | 6282篇 |
皮肤病学 | 716篇 |
神经病学 | 1544篇 |
特种医学 | 724篇 |
外国民族医学 | 11篇 |
外科学 | 4474篇 |
综合类 | 5982篇 |
现状与发展 | 9篇 |
预防医学 | 1876篇 |
眼科学 | 1944篇 |
药学 | 3249篇 |
9篇 | |
中国医学 | 856篇 |
肿瘤学 | 3265篇 |
出版年
2024年 | 39篇 |
2023年 | 483篇 |
2022年 | 663篇 |
2021年 | 1373篇 |
2020年 | 1065篇 |
2019年 | 1013篇 |
2018年 | 1082篇 |
2017年 | 1017篇 |
2016年 | 1015篇 |
2015年 | 1172篇 |
2014年 | 1875篇 |
2013年 | 2198篇 |
2012年 | 1814篇 |
2011年 | 2129篇 |
2010年 | 1869篇 |
2009年 | 1858篇 |
2008年 | 1950篇 |
2007年 | 2067篇 |
2006年 | 1875篇 |
2005年 | 1854篇 |
2004年 | 1580篇 |
2003年 | 1392篇 |
2002年 | 1349篇 |
2001年 | 1227篇 |
2000年 | 1018篇 |
1999年 | 981篇 |
1998年 | 924篇 |
1997年 | 875篇 |
1996年 | 733篇 |
1995年 | 612篇 |
1994年 | 644篇 |
1993年 | 541篇 |
1992年 | 494篇 |
1991年 | 420篇 |
1990年 | 445篇 |
1989年 | 349篇 |
1988年 | 325篇 |
1987年 | 267篇 |
1986年 | 242篇 |
1985年 | 385篇 |
1984年 | 302篇 |
1983年 | 215篇 |
1982年 | 257篇 |
1981年 | 210篇 |
1980年 | 177篇 |
1979年 | 129篇 |
1978年 | 104篇 |
1977年 | 77篇 |
1976年 | 62篇 |
1974年 | 21篇 |
排序方式: 共有10000条查询结果,搜索用时 625 毫秒
1.
Defining con-founders that affect the reliability of diagnostic tests for coronavirus disease 2019 is vital to breaking the chain of infection. The elderly population is a higher risk group for the emerging virus. However, gender seems to exert a critical role in modifying the infection risk among women owing to hormonal changes. The menopause transition is an exceptional period for older women where the protective and immunomodulatory effects of the estrogen hormone are lost. Accordingly, attention should be given to postmenopausal women since they will have an increased risk compared to their pre-menopausal peers. 相似文献
2.
《Value in health》2022,25(6):1010-1017
ObjectivesSurvival extrapolation for chimeric antigen receptor T-cell therapies is challenging, owing to their unique mechanistic properties that translate to complex hazard functions. Axicabtagene ciloleucel is indicated for the treatment of relapse or refractory diffuse large B-cell lymphoma after 2 or more lines of therapy based on the ZUMA-1 trial. Four data snapshots are available, with minimum follow-up of 12, 24, 36, and 48 months. This analysis explores how survival extrapolations for axicabtagene ciloleucel using ZUMA-1 data can be validated and compared.MethodsThree different parametric modeling approaches were applied: standard parametric, spline-based, and cure-based models. Models were compared using a range of metrics, across the 4 data snapshot, including visual fit, plausibility of long-term estimates, statistical goodness of fit, inspection of hazard plots, point-estimate accuracy, and conditional survival estimates.ResultsStandard and spline-based parametric extrapolations were generally incapable of fitting the ZUMA-1 data well. Cure-based models provided the best fit based on the earliest data snapshot, with extrapolations remaining consistent as data matured. At 48 months, the maximum survival overestimate was 8.3% (Gompertz mixture-cure model) versus the maximum underestimate of 33.5% (Weibull standard parametric model).ConclusionsWhere a plateau in the survival curve is clinically plausible, cure-based models may be helpful in making accurate predictions based on immature data. The ability to reliably extrapolate from maturing data may reduce delays in patient access to potentially lifesaving treatments. Additional research is required to understand how models compare in broader contexts, including different treatments and therapeutic areas. 相似文献
3.
Rupa Narayan MD Traci M. Blonquist MS Ashkan Emadi MD PhD Robert P. Hasserjian MD Meghan Burke BS Christopher Lescinskas BS Donna S. Neuberg ScD Andrew M. Brunner MD Gabriela Hobbs MD Hanno Hock MD PhD Steven L. McAfee MD Yi-Bin Chen MD Eyal Attar MD Timothy A. Graubert MD Christina Bertoli MSN Jenna A. Moran MSN Meghan K. Bergeron MSN Julia E. Foster MSN Aura Y. Ramos BSN Tina T. Som BSN Megan K. Vartanian BSN RN Jennifer L. Story LPN Kristin McGregor MS Molly Macrae BS Tanya Behnan BS Margaret C. Wey PhD Jessica Rae BSN Frederic I. Preffer PhD Patricia Lesho BA Vu H. Duong MD Mason L. Mann BA Karen K. Ballen MD Christine Connolly BS Philip C. Amrein MD Amir T. Fathi MD 《Cancer》2020,126(6):1264-1273
4.
5.
6.
7.
目的 观察单次9 h高压氧(hyp erbaric oxygen,HBO)治疗对局灶性脑梗死大鼠凋亡诱导因子
(apoptosis-inducing factor,AIF)、线粒体膜电位(mitochondrial membrane potential,MMPo)的影响,探讨
HBO治疗的神经保护作用。
方法 108只SD大鼠制作永久性大脑中动脉闭塞模型,随机分为对照组和HBO组,每组各54只。造
模成功3 h后,HBO组实行HBO干预,压力0.2 MPa持续9 h,对照组呼吸常压空气。采用Garcia评分评估
大鼠神经功能,比较两组造模后13 h、24 h和72 h神经功能改善情况,并在各时间点检测大鼠缺血半
暗带脑组织凋亡细胞数、线粒体和细胞核AIF表达及MMPo水平。
结果 ①神经功能评分:HBO组13 h(P <0.001)、24 h(P =0.04)神经功能评分改善比对照组更明显。
②凋亡细胞数:HBO组13 h、24 h凋亡细胞数较对照组更少(均P <0.001)。③AIF在线粒体和细胞核的
表达:13 h、24 h、72 h各时间点HBO组AI F在线粒体的表达均较对照组多(均P <0.001);各时间点HBO
组AIF在细胞核的表达均较对照组少(均P <0.001)。④MMPo:各时间点HBO组MMPo均高于对照组(均
P <0.001)。
结论 HBO治疗可改善大鼠神经功能,稳定MMPo,抑制AIF由线粒体向细胞核转移可能是其神经保
护作用的机制之一。 相似文献
8.
《Mayo Clinic proceedings. Mayo Clinic》2019,94(7):1321-1329
Immune checkpoint inhibitors are molecules that increase the endogenous immune response against tumors. They have revolutionized the field of oncology. Since their initial approval for the treatment of advanced melanoma, their use has expanded to the treatment of several other advanced cancers. Unfortunately, immune checkpoint inhibitors have also been associated with the emergence of a new subset of autoimmune-like toxicities, known as immune-related adverse events. These toxicities differ depending on the agent, malignancy, and individual susceptibilities. Although the skin and colon are most commonly involved, any organ may be affected, including the liver, lungs, kidneys, and heart. Most of these toxicities are diagnosed by excluding other secondary infectious or inflammatory causes. Corticosteroids are commonly used for treatment of moderate and severe immune-related adverse events, although additional immunosuppressive therapy may occasionally be required. The occurrence of immune-related toxicities may require discontinuation of immunotherapy, depending on the specific toxicity and its severity. In this article, we provide a focused review to familiarize practicing clinicians with this important topic given that the use of immune checkpoint inhibitors continues to increase. 相似文献
9.
《Biomaterials》2015
The aim of this paper is to present a method to produce macroporous thin membranes made of poly (ethyl acrylate-co-hydroxyethyl acrylate) copolymer network with varying cross-linking density for cell transplantation and prosthesis fabrication. The manufacture process is based on template techniques and anisotropic pore collapse. Pore collapse was produced by swelling the membrane in acetone and subsequently drying and changing the solvent by water to produce 100 microns thick porous membranes. These very thin membranes are porous enough to hold cells to be transplanted to the organism or to be colonized by ingrowth from neighboring tissues in the organism, and they present sufficient tearing stress to be sutured with surgical thread. The obtained pore morphology was observed by Scanning Electron Microscope, and confocal laser microscopy. Mechanical properties were characterized by stress–strain experiments in tension and tearing strength measurements. Morphology and mechanical properties were related to the different initial thickness of the scaffold and the cross-linking density of the polymer network. Seeding efficiency and proliferation of mesenchymal stem cells inside the pore structure were determined at 2 h, 1, 7, 14 and 21 days from seeding. 相似文献
10.
《Vaccine》2019,37(35):5059-5066
Background: Hepatitis B virus (HBV) infection is highly endemic in most low income countries including Cambodia. This nationwide serosurvey was conducted to assess the impact of hepatitis B vaccination and to determine whether Cambodia met the WHO regional 2017 target of hepatitis B surface antigen (HBsAg) seroprevalence less than 1% in five-year-old children.Methods: A cross-sectional multi-stage cluster survey was conducted among children born during 2010–2012 and their mothers in Cambodia. HBsAg prevalence was estimated by rapid point-of-care testing, and demographic data, including vaccination history, was collected. Vaccine coverage in children and the prevalence of HBsAg among children and mothers was calculated taking into account the complex survey design. Factors associated with children’s failure to receive timely (within 24 h) vaccination were analysed by multivariate logistic analysis.Findings: A total of 2,520 children 5–7 years old and 2,028 mothers were recruited. In total, 78.4% of children received hepatitis B vaccination birth-dose (HepB-BD); of these, 58.7% were administered ≤ 24 h. Birth at home or “other” location were independent risk factors for children’s failure to receive timely HepB-BD. Overall HBsAg seroprevalence was 4.39% (95%CI: 3.53%–5.45%) among mothers and 0.56% (95%CI: 0.32%–0.98%) among children. The prevalence among children without hepatitis B vaccination was 4.62% (95%CI: 1.31%–14.97%). Among children with a HBsAg-positive mother, prevalence was 10.11% (95%CI: 5.41%–18.11%).Interpretation: Having achieved the 2017 target of less than 1% HBsAg prevalence among 5 years old children, Cambodia can now focus on eliminating mother-to-child transmission of HBV. Moreover, the high HBsAg prevalence among mothers suggests that routine screening with proper linkage to care and treatment is needed. Strengthening measures to improve vaccination coverage further and eliminate mother-to-child transmission by coordinated programming with other services offering additional HBV interventions will help move towards the global goal of hepatitis B elimination by 2030.Funding: As per sources of funding. 相似文献